Labcorp (LH) Stock: Buy, Sell, or Hold?
LH - Labcorp Holdings Inc.
$304.60
-3.51 (-1.14%)
▼
5d:
-1.41%
30d:
-7.02%
90d:
+6.14%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 27, 2026
24d
Get Alerted When LH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LH is fairly valued with market pricing in 1.5% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: LH is fairly valued with market pricing in 1.5% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$392.02
Based on 6.1% avg growth
INTRINSIC VALUE TODAY
$243.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LH is currently trading at $304.60, which is considered oversold relative to its 30-day fair value range of $310.09 to $332.24. The stock's valuation (Forward PE: 15.3) is in line with its historical norms (14.7). At these levels, the market is pricing in 1.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LH is in a strong uptrend. The price is currently testing key support at $303.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LH scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $344.81 (+13.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LH is in a strong uptrend. The price is currently testing key support at $303.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LH scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $344.81 (+13.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$310.09 -
$332.24
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
91.2%
Protect Your Profits
Holding LH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (66/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($344.81)
- NEUTRAL: Market pricing in 1.5% annual earnings growth - fairly valued
- CAUTION: Bottoming setup, but lagging the sector by 20% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$310.09 -
$332.24
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$12.04
(4.0%)
Support & Resistance Levels
Support Level
$303.13
Resistance Level
$323.84
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.35
Wall Street Target
$344.81
(+13.2%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
28.2%
Profit Margin
7.0%
Valuation Premium vs History
+1.5% premium
PE vs Historical
15.4 vs 14.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.5%
(market-implied from PE analysis)
1-Year Target
$309.17
(+2%)
2-Year Target
$313.81
(+3%)
3-Year Target
$318.51
(+5%)
3-Yr Target (if PE normalizes)
(PE: 15→15)
PE COMPRESSION
$305.03
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 8.2%)
$512.18
(+68%)
Base:
(SPY PE: 15.3, Growth: 8.2%)
$385.38
(+27%)
Bear:
(PE: 13.0, Growth: 8.2%)
$327.58
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 25.51 | Current EPS (TTM): $12.08
Bull Case
$556.75
(+83%)
Analyst growth 64.3%, PE expands to 28.1
Base Case
$506.14
(+66%)
Market implied 64.3%, PE stable at 25.5
Bear Case
$209.51
(-31%)
Severe decline -20.0%, PE contracts to 21.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 3:57 AM ET
Data refreshes hourly during market hours. Next update: 4:57 AM
Data refreshes hourly during market hours. Next update: 4:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 43 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 48 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 46 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$278 | 52 HOLD |
Advanced LH Option Strategies
Professional options setups generated by AI based on today's LH price and gamma walls.
